These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11716667)

  • 1. Aspirin and epithelial ovarian cancer.
    Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
    Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular use of analgesic drugs and ovarian cancer risk.
    Moysich KB; Mettlin C; Piver MS; Natarajan N; Menezes RJ; Swede H
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):903-6. PubMed ID: 11489759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic drug use and risk of epithelial ovarian cancer.
    Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
    Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular analgesic use and risk of endometrial cancer.
    Moysich KB; Baker JA; Rodabaugh KJ; Villella JA
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2923-8. PubMed ID: 16365011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
    Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
    Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
    J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of analgesic use and ovarian cancer.
    Rosenberg L; Palmer JR; Rao RS; Coogan PF; Strom BL; Zauber AG; Stolley PD; Shapiro S
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):933-7. PubMed ID: 11008911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular analgesic use and risk of multiple myeloma.
    Moysich KB; Bonner MR; Beehler GP; Marshall JR; Menezes RJ; Baker JA; Weiss JR; Chanan-Khan A
    Leuk Res; 2007 Apr; 31(4):547-51. PubMed ID: 16962170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
    Johnson TW; Anderson KE; Lazovich D; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
    Zhang M; Xie X; Holman CD
    Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
    Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States).
    Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Gebretsadik T; Hampton JM; Stampfer MJ; Willett WC; Egan KM
    Cancer Causes Control; 2006 May; 17(4):459-67. PubMed ID: 16596298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study.
    Anderson JP; Ross JA; Folsom AR
    Cancer; 2004 Apr; 100(7):1515-21. PubMed ID: 15042687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.